Acasă › Diabet de tip 1 › Pennsylvania
Studii clinice pentru Diabet de tip 1 în Pennsylvania
13 studii pentru Diabet de tip 1 caută participanți în Pennsylvania.
Orașe în Pennsylvania
Text oficial al studiului (în engleză)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
În curs de recrutareFaza 3
Vârste de la 1 la 35 · Toate sexele · Actualizat 22 sept. 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
În curs de recrutareFaza 3
Vârste de la 1 la 35 · Toate sexele · Actualizat 22 sept. 2026 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
În curs de recrutareFaza 3
Vârste de la 1 la 25 · Toate sexele · Actualizat 14 sept. 2026 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
În curs de recrutareFaza 2
Vârste de la 4 la 34 · Toate sexele · Actualizat 9 sept. 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
În curs de recrutareFaza 2
Vârste de la 8 la 45 · Toate sexele · Actualizat 8 sept. 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
În curs de recrutareFaza 1/2
Vârste de la 9 la 20 · Toate sexele · Actualizat 2 sept. 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
În curs de recrutareFaza 3
Vârste de la 18 la 65 · Toate sexele · Actualizat 1 sept. 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
În curs de recrutareFaza 2
Vârste de la 5 la 40 · Toate sexele · Actualizat 24 aug. 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
În curs de recrutare
Vârste de la 18 la 65 · Toate sexele · Actualizat 16 iul. 2026 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 13 apr. 2026 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
În curs de recrutareFaza 3
Vârste de la 18 la 65 · Toate sexele · Actualizat 23 mar. 2026 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
În curs de recrutare
Vârste de la 18 la 75 · Toate sexele · Actualizat 3 mar. 2026 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 2 la 45 · Toate sexele · Actualizat 1 iul. 2025 · NCT00097292Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.